Overexpression of HACE1 in gastric cancer inhibits tumor aggressiveness by impeding cell proliferation and migration

Abstract HACE1 E3 ligase was discovered to be down‐regulated in several cancers while its role in regulating tumors was merely understood. This study aimed to explore the specific effect of HACE1 played in gastric tumorigenesis and its potential mechanism. HACE1's expression was found significa...

Full description

Saved in:
Bibliographic Details
Main Authors: Ying‐ling Chen, Dong‐ping Li, Hong‐yue Jiang, Yang Yang, Li‐li Xu, Shun‐cai Zhang, Hong Gao
Format: Article
Language:English
Published: Wiley 2018-06-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.1496
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850108762371653632
author Ying‐ling Chen
Dong‐ping Li
Hong‐yue Jiang
Yang Yang
Li‐li Xu
Shun‐cai Zhang
Hong Gao
author_facet Ying‐ling Chen
Dong‐ping Li
Hong‐yue Jiang
Yang Yang
Li‐li Xu
Shun‐cai Zhang
Hong Gao
author_sort Ying‐ling Chen
collection DOAJ
description Abstract HACE1 E3 ligase was discovered to be down‐regulated in several cancers while its role in regulating tumors was merely understood. This study aimed to explore the specific effect of HACE1 played in gastric tumorigenesis and its potential mechanism. HACE1's expression was found significantly lower in gastric cancer tissues compared with the adjacent normal tissues (P < 0.001). Its protein level in gastric cancer negatively correlated to tumor pathological differentiation (P = 0.019). And in gastric cancer patients with TNM I‐IIIa, those with lower HACE1 protein level had poorer overall survival (P = 0.025). Studies, in vivo and in vitro, showed that overexpressing HACE1 inhibited tumor proliferation and migration, and enhanced cell apoptosis. Besides, ectopic expression of HACE1 down‐regulated the protein level of β‐catenin and inhibited the activity of the Wnt/β‐catenin signaling pathway. All the cellular functions were abolished when we overexpressed inactive HACE1‐deltaHECT. Above all, we demonstrated that HACE1 E3 ligase played a suppressive role in gastric tumorigenesis and inhibited the activity of the Wnt/β‐catenin signaling pathway. Circumventing the decline of HACE1 in early stage of carcinoma may impede the tumorigenesis and malignant process of gastric cancer.
format Article
id doaj-art-ea997cbcc78745eea18abc047c18b56f
institution OA Journals
issn 2045-7634
language English
publishDate 2018-06-01
publisher Wiley
record_format Article
series Cancer Medicine
spelling doaj-art-ea997cbcc78745eea18abc047c18b56f2025-08-20T02:38:17ZengWileyCancer Medicine2045-76342018-06-01762472248410.1002/cam4.1496Overexpression of HACE1 in gastric cancer inhibits tumor aggressiveness by impeding cell proliferation and migrationYing‐ling Chen0Dong‐ping Li1Hong‐yue Jiang2Yang Yang3Li‐li Xu4Shun‐cai Zhang5Hong Gao6Department of Gastroenterology Zhongshan Hospital Fudan University Shanghai 200032 ChinaDepartment of Gastroenterology Zhongshan Hospital Fudan University Shanghai 200032 ChinaDepartment of Gastroenterology Zhongshan Hospital Fudan University Shanghai 200032 ChinaInstitute of Biochemistry and Cell Biology Shanghai Institutes for Biological Sciences Chinese Academy of Sciences Shanghai 200031 ChinaDepartment of Gastroenterology Zhongshan Hospital Fudan University Shanghai 200032 ChinaDepartment of Gastroenterology Zhongshan Hospital Fudan University Shanghai 200032 ChinaDepartment of Gastroenterology Zhongshan Hospital Fudan University Shanghai 200032 ChinaAbstract HACE1 E3 ligase was discovered to be down‐regulated in several cancers while its role in regulating tumors was merely understood. This study aimed to explore the specific effect of HACE1 played in gastric tumorigenesis and its potential mechanism. HACE1's expression was found significantly lower in gastric cancer tissues compared with the adjacent normal tissues (P < 0.001). Its protein level in gastric cancer negatively correlated to tumor pathological differentiation (P = 0.019). And in gastric cancer patients with TNM I‐IIIa, those with lower HACE1 protein level had poorer overall survival (P = 0.025). Studies, in vivo and in vitro, showed that overexpressing HACE1 inhibited tumor proliferation and migration, and enhanced cell apoptosis. Besides, ectopic expression of HACE1 down‐regulated the protein level of β‐catenin and inhibited the activity of the Wnt/β‐catenin signaling pathway. All the cellular functions were abolished when we overexpressed inactive HACE1‐deltaHECT. Above all, we demonstrated that HACE1 E3 ligase played a suppressive role in gastric tumorigenesis and inhibited the activity of the Wnt/β‐catenin signaling pathway. Circumventing the decline of HACE1 in early stage of carcinoma may impede the tumorigenesis and malignant process of gastric cancer.https://doi.org/10.1002/cam4.1496Gastric cancerHACE1migrationproliferationWnt/β‐catenin pathway
spellingShingle Ying‐ling Chen
Dong‐ping Li
Hong‐yue Jiang
Yang Yang
Li‐li Xu
Shun‐cai Zhang
Hong Gao
Overexpression of HACE1 in gastric cancer inhibits tumor aggressiveness by impeding cell proliferation and migration
Cancer Medicine
Gastric cancer
HACE1
migration
proliferation
Wnt/β‐catenin pathway
title Overexpression of HACE1 in gastric cancer inhibits tumor aggressiveness by impeding cell proliferation and migration
title_full Overexpression of HACE1 in gastric cancer inhibits tumor aggressiveness by impeding cell proliferation and migration
title_fullStr Overexpression of HACE1 in gastric cancer inhibits tumor aggressiveness by impeding cell proliferation and migration
title_full_unstemmed Overexpression of HACE1 in gastric cancer inhibits tumor aggressiveness by impeding cell proliferation and migration
title_short Overexpression of HACE1 in gastric cancer inhibits tumor aggressiveness by impeding cell proliferation and migration
title_sort overexpression of hace1 in gastric cancer inhibits tumor aggressiveness by impeding cell proliferation and migration
topic Gastric cancer
HACE1
migration
proliferation
Wnt/β‐catenin pathway
url https://doi.org/10.1002/cam4.1496
work_keys_str_mv AT yinglingchen overexpressionofhace1ingastriccancerinhibitstumoraggressivenessbyimpedingcellproliferationandmigration
AT dongpingli overexpressionofhace1ingastriccancerinhibitstumoraggressivenessbyimpedingcellproliferationandmigration
AT hongyuejiang overexpressionofhace1ingastriccancerinhibitstumoraggressivenessbyimpedingcellproliferationandmigration
AT yangyang overexpressionofhace1ingastriccancerinhibitstumoraggressivenessbyimpedingcellproliferationandmigration
AT lilixu overexpressionofhace1ingastriccancerinhibitstumoraggressivenessbyimpedingcellproliferationandmigration
AT shuncaizhang overexpressionofhace1ingastriccancerinhibitstumoraggressivenessbyimpedingcellproliferationandmigration
AT honggao overexpressionofhace1ingastriccancerinhibitstumoraggressivenessbyimpedingcellproliferationandmigration